STING Agonists/Antagonists: Their Potential as Therapeutics and Future Developments
The cGAS STING pathway has received much attention in recent years, and it has been recognized as an important component of the innate immune response. Since the discovery of STING and that of cGAS, many observations based on preclinical models suggest that the faulty regulation of this pathway is i...
Main Author: | Danilo Guerini |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/7/1159 |
Similar Items
-
Agonists and Inhibitors of the cGAS-STING Pathway
by: Xiaoxuan Yu, et al.
Published: (2024-06-01) -
Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy
by: Xi Chen, et al.
Published: (2024-01-01) -
cGAS-STING pathway in pathogenesis and treatment of osteoarthritis and rheumatoid arthritis
by: XiCheng Yang, et al.
Published: (2024-05-01) -
Advances of MnO2 nanomaterials as novel agonists for the development of cGAS-STING-mediated therapeutics
by: Tangxin Zhang, et al.
Published: (2023-04-01) -
Clinical applications of STING agonists in cancer immunotherapy: current progress and future prospects
by: Bin Wang, et al.
Published: (2024-10-01)